# LEVOCARNITINE
> **ANDA212533** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2021-11-10
## Drug
- **FDA Application Number:** ANDA212533
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVOCARNITINE
- **Generic name:** LEVOCARNITINE
- **Active ingredients:** LEVOCARNITINE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** TRUPHARMA, LLC
- **First approval:** 2021-11-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212533)
---
*MORVS · CC0 1.0*